Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -790 | -536 | -191 | -714 |
| Depreciation Amortization | 3 | 2 | 1 | 0 |
| Accounts payable and accrued liabilities | 215 | -68 | -58 | N/A |
| Other Working Capital | 327 | 119 | -47 | 73 |
| Other Operating Activity | -180 | 104 | 67 | 83 |
| Operating Cash Flow | $-424 | $-379 | $-229 | $-559 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 530 | N/A | 530 | N/A |
| Other Financing Activity | -85 | 449 | 0 | 246 |
| Financing Cash Flow | $445 | $449 | $530 | $246 |
| Beginning Cash Position | 35 | 35 | 35 | 347 |
| End Cash Position | 56 | 105 | 337 | 35 |
| Net Cash Flow | $21 | $69 | $301 | $-312 |
| Free Cash Flow | ||||
| Operating Cash Flow | -424 | -379 | -229 | -559 |
| Free Cash Flow | -424 | -379 | -229 | -559 |